#United States #healthcare #Atlanta #Myasthenia Gravis #UCB Scholarships

UCB Awards Annual Myasthenia Gravis Scholarships

UCB, a leading global biopharmaceutical company, has officially announced the recipients for its yearly Myasthenia Gravis (MG) Scholarships. This year, 15 deserving individuals from across the United States have been awarded scholarships. These scholarships are specifically designed for those living with myasthenia gravis or those who care for someone affected by this debilitating condition. The initiative reflects UCB's commitment to positively impact the MG community beyond essential medical support.

Living with a rare disease such as MG brings a multitude of challenges—physical, emotional, and financial. Aiming to lessen the financial burdens related to higher education, UCB’s scholarship allows recipients to focus on their educational ambitions and career goals. The selected recipients have showcased remarkable traits such as leadership, community service, and unwavering perseverance.

Among this year's recipients are advocates who have passionately raised awareness about rare diseases and have engaged in numerous service initiatives. They have volunteered for patient organizations and contributed significantly to research, peer support programs, and educational efforts within the MG community. Some scholars even balance their academic pursuits with caregiving responsibilities, reflecting a deep commitment to personal growth and community betterment.

Cameron T., one of the scholarship recipients, shared how this financial support will empower him to concentrate on achieving academic excellence. He stressed the importance of turning his personal experiences into a meaningful impact on others. UCB’s selection committee comprises both healthcare professionals specializing in neuromuscular diseases and individuals affected by MG, ensuring a thorough understanding of each applicant's background and aspirations.

Kimberly Moran, the Senior Vice President and Head of U.S. Rare Diseases at UCB, expressed continual inspiration drawn from the stories of those living with myasthenia gravis. She emphasized the ambition and talent present within this community and reaffirmed UCB's dedication to supporting these scholars as they strive to achieve their educational and professional goals.

This year's scholarship recipients represent a wide array of passion and resilience. They include high school graduates, undergraduate and graduate students from various educational paths—ranging from health sciences to engineering, public health, social work, and advocacy. Notably, their journeys not only highlight their individual strengths but also underline the collective spirit of the MG community, which stands united in the face of adversity.

In recognizing the unique challenges that come with living with MG or caring for someone with this condition, UCB's scholarship program furthers its goal of empowering individuals affected by myasthenia gravis. By supporting these scholars, UCB hopes to enable them to acquire new skills and pursue meaningful career paths, fostering contributions that reverberate throughout their communities.

The recipients of the 2026 UCB Myasthenia Gravis Scholarships are:

• - Aleksander from Carmel Valley, California
• - Brady G. from Creston, Washington
• - Cameron T.
• - Delaney N. from Tempe, Arizona
• - Elisa R.
• - Jodi D. from Seminole, Florida
• - Laura C. from Rockfield, Kentucky
• - Lily B.
• - Michael Shaye V. from Fort Salonga, New York
• - Naiya A. from Lauderhill, Florida
• - Phoebe M. from Eden Prairie, Minnesota
• - Taylor

It's important to note that some recipients have chosen to remain anonymous, but their names are included with permission where given. The UCB Myasthenia Gravis Scholarship program stands as a beacon of hope and empowerment, demonstrating the profound impact that educational support can have on lives shaped by rare diseases.

For more information about the scholarship program, visit UCB Myasthenia Gravis Scholarship. The UCB Myasthenia Gravis Scholarship is a registered trademark of the UCB Group of Companies.